Inhibitor-protected amoxicillin with increased amoxicillin content and active ingredients ratio of 14:1: the use for treatment of community-acquired respiratory infections and ENT infections in children. Expert Council Resolution

For citation: Kozlov R.S., Sinopalnikov A.I., Zaitseva O.V., Zyryanov S.K., Karpova E.P., Radzig E.Yu., Zaitseva S.V., Lokshina E.E., Stetsyuk O.U., Andreeva I.V. Inhibitor-protected amoxicillin with increased amoxicillin content and active ingredients ratio of 14:1: the use for treatment of community-acquired respiratory infections and ENT infections in children. Expert Council Resolution. Clinical review for general practice. 2021; 2: 6–14. DOI: 10.47407/kr2021.2.1.00036

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.